Skip to content

F&G Annuities & Life stock

FGNYSE

F&G Annuities & Life, Inc., Financial ServicesISIN US30190A1043

$23.62▼ $1.18 (−4.8%)Closing price of 12 Nov 2026

57Score 57 out of 100, Neutral

Turn on early warning

Price and trend

60 / 100

Price history

−29% in one year

The chart shows daily closes over 4 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 7.6% below it.

Trend change

Since August 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 68).

Distance to the high

The price is 32% below its 52-week high. Largest decline in 4 years: 61% (December 2024 to October 2026).

Chart figures for advanced users
SMA 50$21.88
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$25.56
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)68
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$18.90
The lowest closing price of the last twelve months.
Resistance$34.93
The highest closing price of the last twelve months.
Market cap
$3.29B
Div. yield
4.03%
12 months
3.3
includes one-off items, adjusted 7.6
Fair value
$77.20

Snapshot

Computed from the data by fixed rules, no AI

  • F&G Annuities & Life, Inc. belongs to the Insurance (Life) industry (United States) and, with a market value of $3.13B, is number 30 of 33 companies in its industry on MEQIRI.
  • In fiscal 2025 it earned $265M (down 58.5% year on year).
  • MEQIRI Score 57 out of 100 (Neutral): rank 774 of 976 in Financial Services, median 68.
Show more
  • Our model puts fair value at $77.20, with the price 68% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • High return on equityReturn on equity 22.6% over the last 12 months.Profitability 71
  • Share buybacksShare count down 13% since 2020.Capital allocation 88
  • High dividend yieldDividend yield 4.03%, Insurance (Life) median 2.29%.Capital allocation 88

Weaknesses

  • Earnings per share fallingDown 30.8% a year since 2021.Growth 24
  • High leverageTotal assets 22.5 times equity.Stability 32
57/ 100
MEQIRI Score
Neutral

Its standout strengths are valuation and capital allocation, while stability and growth hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

The fundamentals are in the middle range.

Profit consistency50% of years
Cash conversion (free cash flow to earnings)not used for financials
ROE (12 months)22.6%
Positive free cash flownot used for financials
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What lowers it

  • low growth grade (crashed less often in the backtest)

Valuation

Valuation signal

Possible value trap
Price
$24.80
Fair value
$77.20
Gap to fair value
−68%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $55.14 and expensive above $128.66 (uncertainty high, based on the price swings of the past year).

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $64.33, at 7.8% it would be $96.49.

Possible value trap: looks cheap, but high risk, weak growth.

Valuation metrics

0.73
22.6%
last 12 months, profit over average equity
Fair value (model)
$77.20

From the excess return model alone; the profit includes one-off items, so there is no industry value.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

10 years

In the twelve months to 30 Sep 2026, revenue rose 5.2% on the twelve months before. Up to 2021 the bars include businesses that were later spun off or sold. On a comparable basis, as restated in the SEC annual reports, revenue grew 9.6% a year.

Margins

10 years
  • Operating margin
  • Net margin

In fiscal 2025: operating 6%, net 5%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out. Last 12 months: net 19%.

Debt & balance sheet

latest quarter
0.5
Equity
$4.37B
2.51
Cash & equivalents
$52.27B

For banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.

Earnings

Next earnings
18 Feb 2027in 98 days
Last reported
5 Nov 2026EPS reported $0.74 (expected $0.66)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20261 analyst
Earnings per share
$2.910.0%
Revenue
$6.01B0.0%
Fiscal 20271 analyst
Earnings per share
$4.630.0%
Revenue
$6.34B0.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: −6.7%

Quarter in line with expectations; targets unchanged, such as the operating expense ratio falling to about 45 basis points by 2027 and an RBC ratio above 400%.

Supporting passage from the call, verbatim
“We have reduced the operating expense ratio from 60 basis points at the end of 2024 to 50 basis points at year-end 2025 and expect further improvement to approximately 45 basis points by year-end 2027 or a cumulative 15 basis point or 25% improvement over the 3-year period.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 6 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

One insider bought on the open market in the last 6 months, $5,015 in total.

  • Murphy ConorPurchase

    30 Sept 2026, CEO and President

    Shares
    231.3
    Price
    $21.68
    Value
    $5,015

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at F&G Annuities & Life

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

976 rated companies in Financial Services

Rank 774 of 976
774/ 976
This company
57
Sector median
68

Categories against the sector median

ProfitabilityMedian of 976 companies71 (median 57)14 above the median
GrowthMedian of 976 companies24 (median 67)43 below the median
FundamentalsMedian of 976 companies60 (median 80)20 below the median
ValuationMedian of 929 companies with a value100 (median 73)27 above the median
StabilityMedian of 976 companies32 (median 78)46 below the median
Capital allocationMedian of 976 companies88 (median 56)32 above the median
Technical analysisMedian of 976 companies60 (median 70)10 below the median
MomentumMedian of 976 companies42 (median 70)28 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Insurance (Life)

The next larger and next smaller companies by market value

All 33 Insurance (Life) stocks

ETFs that hold F&G Annuities & Life

Held by 15 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
iShares S&P SmallCap 600 UCITS ETFIUS30.04%0.30%€2.28B
Avantis Global Small Cap Value UCITS ETFAVWS0.04%0.39%€1.47B
Xtrackers Russell 2000 UCITS ETF 1CXRS20.03%0.30%€2.17B
Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral since 7 Nov 2026, previously Weak
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy